174 related articles for article (PubMed ID: 31450275)
21. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone.
Suefuji H; Ohshima K; Karube K; Kawano R; Nabeshima K; Suzumiya J; Hayabuchi N; Kikuchi M
Int J Cancer; 2005 May; 114(6):896-901. PubMed ID: 15645433
[TBL] [Abstract][Full Text] [Related]
22. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
[TBL] [Abstract][Full Text] [Related]
23. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
Philip AZ
J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
[TBL] [Abstract][Full Text] [Related]
25. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
[TBL] [Abstract][Full Text] [Related]
27. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
28. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
Robinson AC; Nachar VR
J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
[TBL] [Abstract][Full Text] [Related]
29. Epidermotropic presentation by splenic B-cell lymphoma: The importance of clinical-pathologic correlation.
Hedayat AA; Carter JB; Lansigan F; LeBlanc RE
J Cutan Pathol; 2018 Apr; 45(4):299-304. PubMed ID: 29377231
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
31. BRAF
Vaughn JL; Freitag CE; Hemminger JA; Jones JA
J Med Case Rep; 2017 Apr; 11(1):92. PubMed ID: 28376906
[TBL] [Abstract][Full Text] [Related]
32. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
33. Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
Lyu R; Wang T; Wang Y; Xiong W; Wang H; Yan Y; Wang Q; Liu W; An G; Huang W; Sui W; Xu Y; Zou D; Wang J; Qiu L; Yi S
Br J Haematol; 2021 Sep; 194(5):862-869. PubMed ID: 34328213
[TBL] [Abstract][Full Text] [Related]
34. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
35. t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma.
Gomyo H; Kajimoto K; Maeda A; Mizuno I; Funada Y; Koizumi T; Fukui E; Hanioka K; Ogura M; Murayama T
Hematology; 2007 Aug; 12(4):315-8. PubMed ID: 17654058
[TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
37. CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report.
Hashimoto Y; Omura H; Tanaka T; Hino N; Nakamoto S
J Clin Exp Hematop; 2012; 52(3):185-91. PubMed ID: 23269078
[TBL] [Abstract][Full Text] [Related]
38. Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
Cohen JM; Nazarian RM; Ferry JA; Takvorian RW; Carter JB
Am J Dermatopathol; 2015 Jan; 37(1):e1-4. PubMed ID: 25238446
[TBL] [Abstract][Full Text] [Related]
39. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
[TBL] [Abstract][Full Text] [Related]
40. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
